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Abstract: Phenylpropanoid volatile components in plants are useful and valuable not only as
flavorings, but also as medicines and food supplements. The pharmacological actions and toxicities
of these compounds have been well studied but their synthetic pathways are generally unclear. In this
study, we mined expressed sequence tag libraries of pure strains of perilla maintained for over 30 years
for their oil type and conducted gas chromatography-mass spectrometry analyses of the perilla oils to
confirm the presence of monohydrates speculated to be intermediates of the phenylpropene synthetics
pathways. These putative monohydrate intermediates and their regioisomers were synthesized to
identify the reaction products of assays of heterologously expressed enzymes. An enzyme involved
in the synthesis of a phenylpropanoid volatile component was identified in perilla. Expression of this
enzyme in Saccharomyces cerevisiae showed that it is a member of the cytochrome P450 family and
catalyzes the introduction of a hydroxy group onto myristicin to form an intermediate of dillapiole.
The enzyme had high sequence similarity to a CYP71D family enzyme, high regiospecificity, and
low substrate specificity. This study may aid the elucidation of generally unexploited biosynthetic
pathways of phenylpropanoid volatile components.
Keywords: phenylpropanoid; volatile compound; molecular cloning; cytochrome P450; biosynthetic
pathway; perilla
1. Introduction
Perilla (Perilla frutescens Britton var. crispa W. Deane) is a common culinary herb in East and
Southeast Asia, and types of perilla that principally contain perillaldehyde, a monoterpene (MT)
compound, in their essential oils are used pharmaceutically in China and Japan. Essential oils of perilla
can be classified into more than 10 types [1], which are roughly divided into two groups based on
the structures of their constituents [2]: MT-type oils, and phenylpropene (PP)-type oils whose main
constituents are elemicin, myristicin, dillapiole, and nothoapiole (Figure 1). This biosynthetic pathway
of perilla oil is genetically controlled [3,4], and the functions of each gene can be determined by
cloning the enzymes that catalyze the relevant reaction steps in the biosynthetic pathway. The enzymes
that catalyze the formation of MT-type oils, such as limonene synthase, geraniol synthase, linalool
synthase, and perillaldehyde synthase, were previously characterized [5–7], whereas no PP-type
synthases have been reported to date. Known phenylpropanoid volatile components include anethole
in fennel, apiole in parsley, eugenol in clove, and myristicin in nutmeg (Figures 1 and 2), and their
pharmacological actions and toxicities are well studied due to their use as pharmaceuticals and as
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flavorings. For example, myristicin is used to treat rheumatism and anxiety in traditional medicine.
Risk assessment of myristicin using the margin of exposure approach has been conducted because of
its potential genotoxicity or carcinogenicity [8]. Dillapiole, which is found mainly in dill, has been
reported to have cytotoxic effects [9]. However, only a few enzymes involved in the synthesis of these
compounds have been isolated and reported, and these known enzymes catalyze the formation of
compounds with simple side groups [10].
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(E)-asarone (Figure 2) [11]. (E)-Asarone is structurally similar to PP-type oil components [12,13] and 
is likely formed through a PP-type oil component pathway, although the details are currently 
unknown. However, the (Z)-asarone isomer was reported to be toxic [14] and (E)-asarone may be 
carcinogenic [15], and therefore it should always be certified that no perilla plants containing 
(E)-asarone are present in the plant material used to prepare the pharmaceutical formulation. In 
order to find plants including this toxic compound and remove them from medicine ingredients, 
purity tests using liquid chromatography, optimized to separate perillaldehyde and (E)-asarone, are 
defined in the Japanese Pharmacopoeia. 
The main constituents of PP-type perilla oil are elemicin, myristicin, dillapiole, and nothoapiole, 
and are likely synthesized from phenylalanine (Figure 1). The reaction steps to all four compounds 
are genetically controlled based on crossing experiments using pure strains developed by repeated 
self-pollination, and on detailed gas chromatography (GC) analyses of perilla essential oils [2,16]. 
Previous reports on the synthesis of alkaloids suggested that methoxy or methylenedioxy groups are 
formed in the synthetic pathways leading to PP-type oil components and may involve hydroxylation 
or cyclization reactions by cytochrome P450 (hereafter, “P450”) [17]. P450 enzymes catalyze different 
reactions, such as oxidation, hydroxylation, epoxidation, and dealkylation, and are involved in the 
synthesis of many plant secondary metabolites. Their low substrate specificity and high reaction 
regio- and stereo-specificity are beneficial for generating useful compounds, making their catalytic 
mechanisms an attractive target of study. 
Here we describe the isolation of a P450 enzyme involved in the synthesis of dillapiole in 
PP-type perilla oils using expressed sequence tag (EST) libraries of pure strains of perilla. The perilla 
strains have been developed and maintained for more than 30 years through repeated 
Figure 1. Putative biosynthetic pathway of phe l ene ( P)-type oils in perilla. In the text, the oil
types of each strain of perilla are represented as PP-em, PP-m, PP-md, PP-emd, and PP-mdn, meaning
that each strain mainly contains elemicin + myristicin, myristicin, myristicin + dillapiole, elemicin +
myristicin + dillapiole, and myristicin + dillapiole + nothoapiole, respectively.
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Perilla p nts, whose major aromatic co p u d is perillaldehyde, are used as herbal medicine
for Kampo prescriptions in Japan. Those perilla plants that are rich in perillaldehyde do not contain
(E)-asarone (Figure 2) [11]. (E)-Asarone is structurally similar to PP-type oil components [12,13] and is
likely formed through a PP-type oil component pathway, although the details are currently unknown.
However, the (Z)-asarone isomer was reported to be toxic [14] and (E)-asarone may be carcinogenic [15],
and therefore it should always be certified that no perilla plants containing (E)-asarone are present in
the plant material used to prepare t e pharmaceutical formulation. In order to fin plants including this
toxic compound and remove the from medicine ingredients, purity tests using liquid chromatography,
optimized to separ te perillaldehyde and (E)-asarone, are defined in the Japanese Pharmacopoeia.
The main constituents of PP-type perilla il elemicin, myristicin, dillapiole, and nothoapiole,
and are likely synthesized from phenylalanine (Figure 1). The reaction steps to all four compounds
are genetically controlled based on crossing experiments using pure strains developed by repeated
self-pollination, and on detailed gas chromatography (GC) analyses of perilla essential oils [2,16].
Previous reports on the synthesis of alkaloids suggested that methoxy or methylenedioxy groups are
formed in the synthetic pathways leading to PP-type oil components and may involve hydroxylation
or cyclization reactions by cytochrome P450 (hereafter, “P450”) [17]. P450 e zymes catalyze different
reactio s, such as oxidation, hydrox lation, epoxidation, and de lkylation, and are involved in the
synth s s of many plant secondary metabolites. Their low substrate specificity and high reaction
regio- and stereo-specificity e beneficial for generating useful compounds, making their catalytic
mechanisms an attractive target of study.
Here we describe the isolation of a P450 enzyme involved in the synthesis of dillapiole in PP-type
perilla oils using expressed sequence tag (EST) libraries of pure strains of perilla. The perilla strains have
been developed and maintained for more than 30 years through repeated self-pollination. The high
purity of these strains allows for the selection of P450 sequences that may be involved in the biosynthesis
of each oil component by comparing the expression levels of those sequences [18].
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2. Results
2.1. Isolation of a P450 Sequence from Perilla
P450-like sequences that are specifically expressed in perilla strains whose essential oils contain
mainly dillapiole were identified. Contig 49487 was selected from our EST library because it had
the largest difference in reads per kilobase of exon per million mapped read (RPKM) values of the
sequences studied (Table 1). We PCR-amplified the selected contig using primers based on sequence
information from the EST database, using complementary DNA (cDNA) as a template, then confirmed
the size of the PCR product by agarose-gel electrophoresis. The size of contig 49487 was in accordance
with the sequence information. The full-length sequence of contig 49487 was determined by RACE
methods. The sequence Pf-49487 (GenBank Accession No. LC476554) encoded 505 amino acids
(57 kD, Figure 3), and regions characteristic of P450s, such as a proline-rich region, an oxygen-binding
pocket, and a heme-binding region, were conserved [19]. BLAST analysis showed that the amino
acid sequence of Pf-49487 shared 56% identity with that of the Sesamum indicum premnaspirodiene
oxygenase-like enzyme (predicted) (GenBank Accession No. JP653840) and this was the highest
similarity among all entries in the database. Premnaspirodiene oxygenase is a hydroxylase classified as
a member of the CYP71D family. Pf-49487 had a 49% amino acid sequence identity to the characterized
Hyoscyamus muticus premnaspirodiene oxygenase (GenBank Accession No. EF569601) [20]. Cinnamate
4-hydroxylase from Arabidopsis thaliana (GenBank Accession No. NP180607) was a member of the P450
family that hydroxylates the aromatic ring of phenylpropanoid compounds and shared 28% sequence
identity with Pf-49487 at the amino acid level. Based on the standardized P450 nomenclature system,
Pf-49487, is in the CYP71D subfamily and was named CYP71D558.
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Figure 3. Alignment of the a ino acid sequences of Pf-49487. P : yoscya us uticus
pre naspirodiene oxygenase ( enBank ccession o. EF569601), 4 : cinna ate 4-hydroxylase
( rabidopsis thaliana) (GenBank Accession No. NP180607). The following conserved regions of P450 are
underlined: the proline-rich region, the oxygen-binding pocket, and the heme-binding region from
upstream of the sequence. Black background indicates 100% amino acid identity among the three
clones and gray background indicates greater than 50% amino acid identity.
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Table 1. Reads per kilobase of exon per million mapped read (RPKM) values of contig 49487 and
77404. Oil type C means that the strain mainly contains citral, a monoterpene (MT)-type oil component.
Contig 49487 had the largest difference in RPKM values between PP-type strains containing dillapiole
(i.e., strains 16, 25, and 5316) and others. Contig 77404 showed the second largest difference in
RPKM values.
Strain (Oil Type)
Contig 10 (PP-em) 12 (PP-m) 16 (PP-md) 25 (PP-emd) 5316 (PP-mdn) 5717 (C)
49487 0.0824 0.0968 68.4 23.7 56.7 0.325
77404 0.260 0.459 1.10 1.40 1.70 0.446
2.2. Comparison of Pf-49487 Expression among Strains of Phenylpropene (PP)-Type Perilla
Quantitative reverse transcription-PCR (RT-PCR) was used to compare the Pf-49487 expression
levels in various strains using RNAs isolated from different oil types of perilla: strain 12 of PP-m, strain
25 of PP-emd, and strain 5316 of PP-mdn (Figures 1 and 4). The difference in expression level among
oil types is similar to the RPKM values in the EST library used for the isolation of Pf-49487, namely,
strain 12: 0.0968, strain 25: 23.7, strain 5316: 56.7 (Table 1). These ratios are believed to be relevant to
the dillapiole content (%) in oils, namely, strain 12: 0%, strain 25: 9.01%, strain 5316: 21.13% [4,16].
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2.3. Heterologous Expression and Functional Analysis of Pf-49487
P450 enzymes with a bound carbon monoxide (CO) molecule show an absorption spectrum
peak at ca. 450 nm, and heterologously expressed P450 enzymes with such an absorption maximum
generally have high activity. The reduced CO-difference spectrum of the microsomal fraction of
yeast harboring the Pf-49487 expression plasmid was measured and a peak at 448 nm was observed,
suggesting that Pf-49487 has P450 activity (Figure 5).
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Figure 5. The reduced carbon monoxide (CO)-difference spectrum of the microsomal fraction of yeast
harboring the Pf-49487 expression plasmid.
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The catalytic reaction of Pf-49487 was analyzed using the microsomal fraction and myristicin
as a substrate by GC-mass spectrometry (MS). The reaction product was 6-allyl-4-methoxy-1,3-
benzodioxol-5-ol (Table 2, compound 20), a hydroxylated myristicin (Figure 6). When methyl eugenol
or elemicin were used as substrates, the hydroxylated products 6-allyl-2,3-dimethoxyphenol (Table 2,
compound 5) and 6-allyl-2,3,4-trimethoxyphenol (Table 2, compound 31) were obtained, respectively
(Figure 6). Dillapiole, eugenol, limonene, and geraniol were not substrates for this enzyme (Table 3).
Table 2. Synthesized allylphenols used in this study.
Formula Name (Compound Number) Mass Spectra RetentionTime (min)
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Although Pf-49487 converted ethyl eugenol to compound 5 (Table 3), compound 5 was absent 
in oil prepared from strain 5316, which expresses a higher level of Pf-49487, whereas 
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5-Allyl-6,7-dimeth xy-1,3-
benzodioxol-4-ol (30)
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Although Pf-49487 converted ethyl eugenol to compound 5 (Table 3), compound 5 was absent 
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Although Pf-49487 converted m thyl eugenol to compound 5 (Table 3), compound 5 was absent 
in oil prepared from strain 5316, which expresses a higher level of Pf-49487, whereas 
5-allyl-2,3-dim thoxyphenol (Table 2, compound 14), compound 20, 
31
Although Pf-49487 converted me hyl eugenol to comp und 5 (Table 3), compound 5 was a
in oil prepare fr m strain 5316, which expresses a higher level of Pf-49487, whereas 5- llyl-2,3-
dimethoxyph n l (Table 2, co pound 14), compound 20, 5-allyl-6,7-dimethoxy-1,3-benzodioxol-4-ol
(Table 2, compound 30), and co pou d 3 were pres nt. Th e results suggest that Pf-49487 does not
convert meth eugenol to comp und 5 in perilla.
The use of elemicin as a substrate result d in lower activity than did the use of myristicin (Table 3).
This result suggests t at myristicin and not elemi in is the main substrate for Pf-49487.
We performed kinetic analyses of the Pf-49487 reaction using myristicin as substrate. The P450
concentration in the microsomal fraction was determined to be 1.03 µM from the reduced CO-difference
spectrum and the Km, turnover number (kcat), and catalytic efficiency (kcat/Km) values were
9.1 µM, 15 min−1, and 1.65 × 10−6 min−1 M−1, respectively. The Km value for the oxidization of
premnaspirodiene by premnaspirodiene oxygenase (whose amino acid sequence is most similar to
Pf-49487) was 14 µM, similar to that of Pf-49487 [20]. The optimum pH of Pf-49487 was approximately
7.5 (Figure 7), similar to that of premnaspirodiene oxygenase [20].
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Figure 6. Gas chro atography-mass spectrometry (GC-MS) profiles of the reaction products.
(A–F), Total ion chromatograms of the products obtained using the control (A,C,E) and the microsomal
fraction prepared from yeast harboring Pf-49487 (B,D,F). The substrates are myristicin (A,B), methyl
eugenol (C,D), and elemicin (E,F). The controls were incubated without the cofactor NADPH. The peak
with a retention time of 24 min is the internal standard, eugenol. (G–I), Mass spectra of the products
formed by Pf-49487 with myristicin, methyl eugenol, and elemicine as the substrates, respectively.
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Table 3. Relative activity of Pf-49487.
Formula Substrate Activity (%)
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3. Discussion
Pf-49487 is a P450 enzyme n perilla that introduces a hydroxy group onto myri ticin to form a
dillapiole intermediate (compou d 20). Pf-49487 catalyzes t e hydroxylation of ethyl eugenol and
elemicin at a position similar to that of compound 20 but is unreactive towards limonene and geraniol,
which are MT-type il co ponents, s well as dillapiole and eugenol, which are phenylpropanoi
compounds. These results indicate that Pf-49487 exhibits rather low subs rate specifici y and high
reg specificity. Pr mnas irodiene oxygenase, whos sequence is most similar to that of Pf-49487,
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has similar properties [20]. Other members of the CYP71D family also have high regiospecificity,
namely the limonene hydroxylases CYP71D13 and CYP71D18, which hydroxylate the C3 and C6
positions, respectively [21].
The biosynthetic pathways of PP-type oil components have been inferred from the results
of crossing experiments conducted with pure strains of perilla containing elemicin, myristicin,
dillapiole, and nothoapiole as the main oil components, and the genetic control of each step in the
formation of elemicin, dillapiole, and nothoapiole was in accordance with Mendelism [16] (Figure 1).
Phenylpropanoids are believed to be synthesized via the shikimate pathway and the genes for methyl
eugenol formation have been cloned [22]; consequently, methyl eugenol could be a precursor of
PP-type oil components. However, neither methyl eugenol nor compound 5 have been detected in
perilla oil whereas Pf-49487 produces compound 5 from methyl eugenol in vitro. On the other hand,
compound 14 (a putative precursor of elemicin and myristicin) and compound 30 (a putative precursor
of nothoapiole) were present in oil from strain 5316 (PP-mdn). However, compound 14 was not found
in oil from strain 10 (PP-em) and strain 12 (PP-m), even though compound 14 is a likely intermediate of
myristicin and thus was expected to be present in these oils. These findings indicate that the catalytic
patterns and reactivities of enzymes may differ among oil types. Our identification of monohydrate
intermediates of phenylpropanoid compounds in perilla oil suggests that O-methyltransferases or
P450s are involved in perilla biosynthetic pathways and catalyze the generation of methoxy groups or
methylenedioxy bridges from these monohydrate compounds. Our future studies will further explore
these enzymes.
4. Materials and Methods
4.1. Plant Materials
All perilla plants used in this study were grown at the Experimental Station for Medicinal Plant
Research, Graduate School of Pharmaceutical Sciences, Kyoto University. They have been bred and
kept as pure lines through repeated self-pollination [18]. Strain numbers and oil types (Figure 1) of
perilla used in this study were as follows: strain 10, PP-em; strain 12, PP-m; strain 16, PP-md; strain 25,
PP-emd; strain 5316, PP-mdn; strain 5717, C.
4.2. Construction of the Expressed Sequence Tag (EST) Library and Cloning of Pf-49487
The EST library was constructed by the Kazusa DNA Research Institute as described previously [7].
P450-like sequences were selected from the EST library by BLAST analysis and the expression levels of
these sequences were compared between different oil types. High expression level contigs in strains
containing high levels of dillapiole (strains 16, 25, and 5316) were selected and their expression levels
were compared using RPKM values.
We focused on contig 49487, which is most specifically expressed in dillapiole-containing perilla
(Table 1). PCR-amplification was performed for the target sequence, using cDNA as a template.
cDNA was obtained by reverse transcription of RNA isolated from fresh young perilla leaves
(strain 5316) using a RNeasy Plant Mini Kit (Qiagen), and reverse transcription was performed
using RevTra Ace (Toyobo) with primer add2 (5′-CCACGCGTCGACTACTTTTTTTTTTTTTTT-3′).
Primers for PCR-amplification were designed based on sequence information from the EST database.
The forward primer 49487-f1 (5′-TCCGTTCCGTTCCTTCAGAGATCTCGCG-3′) and reverse primer
49487-r1 (5′-GGATGCCTTATCAGTTCAGTCATTGCC-3′) were used for amplifying contig 49487.
The reaction mixture contained 0.2 µM primer, 0.2 mM dNTPs, and 0.025 U µL−1 Blend Taq (Toyobo).
The temperature program started at 94 ◦C for 30 s, followed by 30 cycles of 51 ◦C for 30 s, 72 ◦C for 60 s,
and a final elongation at 72 ◦C for 60 s. The size of contig 49487 corresponded to the sequence information
from the EST database and RACE methods were used to obtain its full-length sequence. 3′-RACE was
performed with the primers add2 and 49487-f2 (5′-AGAAGGTCGGCACAATGGTCAGC TCCATC-3′),
and then nested PCR was performed with the primers amm (5′-GGCCACGCGTCGACTAC-3′)
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and 49487-f3 (5′-TGTAGGTCTGCGTTCGGCACGGTGTGCAAG-3′) in the same reaction mixture
as described above, with a temperature program starting at 94 ◦C for 30 s, followed by 30 cycles
of 55 ◦C (52 ◦C for nested PCR) for 30 s, 72 ◦C for 60 s, and a final elongation at 72 ◦C for 60 s.
The reaction products were electrophoresed in agarose gel, purified using NucleoSpin Gel and PCR
clean-up (Macherey-Nagel), and ligated to the vector pTA2 (Toyobo). Sequences were confirmed using
FASMAC. For 5′-RACE, reverse transcription was performed as described above with primer 49487-r2
(5′-GTAATTGTACCAGCAGACCTCTAGG-3′) or primer 49487-r3 (5′-GGATCATTGTCTTTGAGGACT
TCCTTC-3′) and the reaction products were purified using NucleoSpin Gel and PCR clean-up. After the
addition of poly C using 0.6 U µL−1 TdT (Invitrogen) and 0.2 mM dCTP (Toyobo), PCR was performed
with the primers 5ann (5′-GGCCACGCGTCGACTAGTACGGG(I)(I)GGG(I)(I)GGG(I)(I)G-3′) and
49487-r3 or 49487-r4 (5′-CGATGACACGAGGAACGAGTCGAC-3′), and then nested PCR was
performed with the primers amm and 49487-r3 in the same reaction mixture as described above, with a
temperature program starting at 94 ◦C for 100 s, followed by 25 cycles (30 cycles for nested PCR) of
94 ◦C for 30 s, 50 ◦C (50.5 ◦C for nested PCR) for 30 s, 72 ◦C for 60 s, and a final elongation at 72 ◦C
for 60 s.
4.3. Heterologous Expression of Pf-49487 in Saccharomyces cerevisiae
Pf-49487 was ligated into yeast expression vector pGYR-SpeI containing the S. cerevisiae
NADPH-P450 reductase gene and a SpeI-cloning site [17]. The full-length sequence of Pf-49487 was
amplified by PCR with the forward primer 49487-f4 (5′-ACTAGTATGGAGTCCGATCTCGCAACTG-3′)
and the reverse primer 49487-r5 (5′-ACTAGTTCACGGTGATGTCGGTTCAAATGG-3′) in a reaction
mixture containing 0.3 µM primer, 0.2 mM dNTPs, and 0.02 U µL−1 KOD-Plus (Toyobo) using a
temperature program starting at 94 ◦C for 100 s, followed by 25 cycles of 94 ◦C for 15 s, 52.7 ◦C for
30 s, 68 ◦C for 90 s, and final elongation at 68 ◦C for 90 s. The amplified sequence was ligated into
pTA2 and the nucleotide sequence was confirmed, then Pf-49487 was ligated into pGYR-SpeI and
the vector was introduced into S. cerevisiae strain AH22 using the LiCl method. The recombinant
yeast cells were cultivated, and the microsomal fraction was prepared as previously described [23].
The microsomal fraction was suspended in 100 mM HEPES/NaOH (pH 7.5) and stored at −80 ◦C
until needed. The reduced CO-difference spectrum was measured with a UV1800 spectrophotometer
(Shimadzu) and enzymatic activity was confirmed by the peak at 450 nm [24].
4.4. Enzymatic Assays and Gas Chromatography-Mass Spectrometry (GC-MS) Analyses
Enzymatic reactions were performed in 1-mL volumes in screw-capped glass tubes. Each reaction
mixture was composed of 50 mM HEPES/NaOH (pH 7.5), 0.5 mM NADPH, 0.2 mM substrate, and
1.98 mg mL−1 enzyme preparation. After incubation at 30 ◦C for 15 min, 12 nmol of eugenol was
added as an internal standard, and the reaction mixture was extracted three times with 2 mL of
pentane. The pentane fractions were combined, dehydrated with MgSO4, concentrated under nitrogen,
and analyzed by gas chromatography-mass spectrometry (GC-MS) instrument (6850GC/5975MSD,
Agilent Technologies or GCMS-QP2020 NX, Shimadzu). The compounds were separated on a DB-WAX
column (60 m × 0.25 mm × 0.25 µm, Agilent Technologies, Santa Clara, CA, USA) under the following
conditions: injector, 180 ◦C; oven program starting at 100 ◦C, increasing at 5 ◦C min−1 to 220 ◦C,
and holding at this temperature for 60 min. Helium was used as the carrier gas and column flow was
1.0 mL min−1. The compounds were identified by comparing their retention times and mass spectra
with authentic standards, synthesized samples, or a MS data library (NIST11 or NIST17; National
Institute of Standards and Technology).
For kinetic analyses, 0.78 mg mL−1 enzyme preparations were incubated with myristicin
concentrations ranging from 0.2 to 10 µM. The reaction mixtures were treated as described above and
analyzed by GC-FID (G5000, Hitachi, Tokyo, Japan). Compounds were separated on an InertCap WAX
column (60 m × 0.25 mm × 0.25 µm, GL Sciences) or a DB-WAX column (60 m × 0.25 mm × 0.25 µm,
Agilent Technologies) under the following conditions: injector, 180 ◦C; FID, 220 ◦C; oven program
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starting at 100 ◦C, increasing at 5 ◦C min−1 to 220 ◦C, and holding at this temperature for 40 min.
Assays were repeated independently three times. The P450 concentration in the enzyme preparation
was determined from the reduced CO-difference spectrum using a differential absorption coefficient of
91 mM−1 cm−1 [24].
The optimum pH (ranging from 6.0 to 9.0) was analyzed using 0.2 mM myristicin and 1.65 mg mL−1
enzyme preparation. Assays were performed in the same manner as the kinetic analyses.
4.5. Quantitative RT-PCR
The differences in the expression levels of Pf-49487 between different perilla oil types were
determined using quantitative RT-PCR. Total RNA was isolated from fresh young perilla leaves
(strains 12, 25, and 5316) using the method described above. First-strand cDNAs were synthesized
from 1 µg total RNA using ReverTra Ace and oligo(dT) primer (Takara), and were then purified
using NucleoSpin Gel and PCR clean-up. Quantitative RT-PCR was performed with StepOnePlus
(Applied Biosystems) using THUNDERBIRD SYBR qPCR Mix (Toyobo) following the manufacturers’
protocols, with a temperature program starting at 95 ◦C for 60 s, followed by 40 cycles of 95 ◦C
for 15 s, 60 ◦C for 60 s. The forward primer 49487-f (5′-TGGTGCCTCTCATAATGCTG-3′) and the
reverse primer 49487-r (5′-TCTGAAGGAACGGAACGGAG-3′) were used to amplify Pf-49487, and
the forward primer Histone-f (5′-TCACGAACAAGCCTTTGGAA-3′) and the reverse primer Histone-r
(5′-AAGCCTCACCGTTACCGTC-3′) were used to provide histone transcripts as the internal control
for PCR. Quantitation was performed using the 2−∆∆CT method. Total RNA was extracted in duplicate
and reactions were performed independently three times.
4.6. GC-MS Analysis of Perilla Oil
Perilla essential oils were obtained by extracting approximately 300 g of fresh perilla leaves
(strains 10, 12, and 5316) with diethyl ether overnight at 4 ◦C. The oils were concentrated, dehydrated,
and analyzed by GC-MS as described above. Because these analyses were performed to confirm the
presence of monohydrate intermediates, the oils were highly concentrated; consequently, we focused
on the retention times of the synthesized compounds (Table 2). The chemical profiles of each perilla
strain were previously reported [4,16].
4.7. Chemicals
Chemical reagents were purchased from Nacalai Tesque or Fujifilm Wako Pure Chemical.
Compounds 5, 8, 14, 20, 23, and 30 were synthesized as described below (Figure 8). NMR, MS,
and IR data are shown in Supplementary Data S1. Compound 31 was synthesized as previously
reported [25].
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(F) Synthesis of 5-allyl-7-methoxy-1,3-benzodioxol-4-ol (23). (G) Synthesis of 5-allyl-6,7-dimethoxy-1,3-
benzodioxol-4-ol (30).
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All melting points were uncorrected. Silica gel was used for column chromatography. Commercially
available solvents and reagents were purchased and used without purification.
4.7.1. Synthesis of 6-Allyl-2,3-dimethoxyphenol (5)
1. 2-Benzenesulfonyl-1,3-dibromopropane [219500-61-5] (1): The title compound was prepared
according to the reported procedure as colorless needles [26,27] of mp 93–94 ◦C (EtOAc/hexane).
2. 1-(2-Benzenesulfonylallyloxy)-2,3-dimethoxybenzene (2): 2,3-Dimethoxyphenol (262 mg,
1.70 mmol) was dissolved in dry acetone (17 mL), and to the solution was added K2CO3
(705 mg, 5.10 mmol). The resulting suspension was stirred at room temperature for 10 min, and
2-benzenesulfonyl-1,3-dibromopropane (1) (640 mg, 1.87 mmol) and KI (7 mg, 0.04 mmol) were
added to the suspension. After 3 h, the mixture was filtered through Celite, and the residue was
successively washed with EtOAc. The combined filtrate and washings were concentrated in
vacuo and purified by column chromatography (hexane/EtOAc 4:1) to give 2,3-dimethoxyphenol
(45 mg, 17%) and the title compound (453 mg, 80%) as pale-yellow oils.
3. 6-(2-Benzenesulfonylallyl)-2,3-dimethoxyphenol (3): 1-(2-Benzenesulfonylallyloxy)-2,3-
dimethoxybenzene (2) (436 mg, 1.30 mmol) was dissolved in toluene (1 mL) and heated at 165 ◦C
for 12 h under microwave irradiation. The mixture was concentrated in vacuo and purified by
column chromatography (hexane/EtOAc 7:3) to give the title compound (398 mg, 92%) as a
pale-yellow solid: mp 108–109 ◦C (EtOAc/hexane).
4. 3-Benzenesulfonyl-7,8-dimethoxychromane (4): To a solution of 6-(2-benzenesulfonylallyl)-
2,3-dimethoxyphenol (3) (144 mg, 0.430 mmol) in dry acetone (4 mL), was added K2CO3 (89 mg,
0.64 mmol), and the mixture was heated under reflux for 5 h. The mixture was diluted with EtOAc
and washed with H2O. The aqueous layer was extracted with EtOAc, and the combined organic
layers were washed with brine, dried over Na2SO4, and concentrated in vacuo to give the title
compound as a white solid (140 mg). The crude product was used in the next step without further
purification. The title compound was characterized after recrystallization from EtOAc/hexane,
which gave colorless needles of mp 132–134 ◦C.
5. 6-Allyl-2,3-dimethoxyphenol [450357-58-1] (5): To a solution of the crude 3-benzenesulfonyl-7,8-
dimethoxychromane (4) (140 mg) in EtOAc/MeOH (2:1, 4.5 mL), was added 5% sodium amalgam
(0.93 g, 2.0 mmol) at room temperature, and the mixture was stirred for 4 h. The reaction
was quenched by the addition of solid citric acid (0.39 g), and the mixture was diluted with
EtOAc, washed with saturated aqueous NaHCO3, dried over Na2SO4, and concentrated in
vacuo. The residue was purified by column chromatography (hexane/EtOAc 9:1) to give the title
compound (65 mg, 78% over 2 steps) as a pale-yellow oil.
4.7.2. Alternative Synthesis of 6-Allyl-2,3-dimethoxyphenol (5)
1. 1-(Allyloxy)-2,3-dimethoxybenzene [380621-78-3] (6): The title compound was prepared
from 2,3-dimethoxyphenol (982 mg, 6.37 mmol) according to the reported procedure [28].
After purification by column chromatography (hexane/EtOAc 9:1), the title compound (1.11 g,
90%) was obtained as a colorless oil.
2. 6-Allyl-2,3-dimethoxyphenol [450357-58-1] (5) and 4-Allyl-2,3-dimethoxyphenol [29445-64-5] (7):
A solution of 1-allyloxy-2,3-dimethoxtbenzene (6) (528 mg, 2.72 mmol) in decaline (0.5 mL) was
heated at 200 ◦C under microwave irradiation for 10 h. After cooled to ambient temperature,
the solution was directly purified by column chromatography (hexane/EtOAc 9:1) to give
6-allyl-2,3-dimethoxyphenol (103 mg, 20%) as a pale-yellow oil and a 63:37 mixture of 6-allyl-(5)
and 4-allyl-2,3-dimethoxyphenol (7) (367 mg, 44% and 26%, respectively) as a pale-yellow oil.
4-Allyl-2,3-dimethoxyphenol (7) was characterized as a mixture with the other isomer.
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4.7.3. Synthesis of 2-Allyl-4,5-dimethoxyphenol (8)
2-Allyl-4,5-dimethoxyphenol [59893-87-7] (8) and 2-Allyl-3,4-dimethoxyphenol [66967-26-8] (9):
4-allyloxy-1,2-dimethoxybenzene [29] (515 mg, 2.65 mmol) was dissolved in decaline (0.5 mL) and heated
at 200 ◦C under microwave irradiation for 12 h. After cooled to ambient temperature, the solution was
directly purified by column chromatography (hexane/EtOAc 3:1) to give 2-allyl-4,5-dimethoxyphenol
(8) (68 mg, 13%) as a pale-yellow solid along with a 91:9 mixture of the title compounds (411 mg, 73%
and 7%, respectively) as a pale-yellow oil. 2-Allyl-3,4-dimethoxyphenol (9) was partially separated
as a pale-yellow oil from the mixture by another column chromatography (hexane/EtOAc 3:1) for
characterization. 2-Allyl-4,5-dimethoxyphenol: mp 35–36 ◦C (Et2O/hexane) (lit. 42–42.5 ◦C) [30].
4.7.4. Synthesis of 5-Allyl-2,3-dimethoxyphenol (14)
1. 3-tert-Butyldimethylsiloxy-4,5-dimethoxybenzaldehyde [122271-47-0] (10): To a solution of
3-hydroxy-4,5-dimethoxybenzaldehyde (500 mg, 2.74 mmol) in dry N,N-dimethylformamide
(DMF) (3 mL), were added tert-butylchlorodimethylsilane (496 mg, 3.29 mmol) and imidazole
(466 mg, 6.84 mmol). The mixture was stirred at room temperature for 16 h, diluted with EtOAc,
washed with saturated aqueous NaHCO3 and brine, dried over Na2SO4, and concentrated in
vacuo. The resulting pale-yellow oil, containing mainly the title compound, was used for the next
step without further purification. The 1H NMR was consistent with that reported [31].
2. 3-tert-Butyldimethylsiloxy-4,5-dimethoxybenzenemethanol [111394-55-9] (11): To a solution of
the crude 3-tert-butyldimethylsiloxy-4,5-dimethoxybenzaldehyde (10) in EtOH (24 mL) cooled in
an ice–water bath, was portion-wise added NaBH4 (104 mg, 2.75 mmol). After 15 min, water
was added to the mixture, and most of EtOH was removed from the mixture by evaporation.
The mixture was extracted three times with EtOAc, and the combined organic layers were washed
with brine, dried over Na2SO4, and concentrated in vacuo. The resulting residue was purified
by column chromatography (hexane/EtOAc 3:1) to give the title compound (563 mg, 69% over
2 steps) as a white solid. Recrystallization from hexane gave colorless needles of mp 57–58 ◦C.
The 13C NMR was identical to that reported, while all the 1H NMR chemical shifts differed by
0.18 ppm from the reported values [32].
3. 3-tert-Butyldimethylsiloxy-4,5-dimethoxybenzyl Bromide [111394-56-0] (12): To a solution of
3-tert-butyldimethylsiloxy-4,5-dimethoxybenzenemethanol (11) (315 mg, 1.06 mmol) in dry
CH2Cl2 (10 mL) cooled in an ice–water bath, were added CBr4 (420 mg, 1.27 mmol) and Ph3P
(333 mg, 1.27 mmol). The cooling bath was removed, and the mixture was stirred at room
temperature for 20 min. Volatile materials were removed from the mixture by evaporation, and
the residue was purified by column chromatography (hexane to hexane/EtOAc 97:3) to give the
title compound (305 mg, 80%) as a pale-yellow oil.
4. 5-Allyl-1-tert-butyldimethylsiloxy-2,3-dimethoxybenzene (13): To a mixture of 3-tert-
butyldimethylsiloxy-4,5-dimethoxybenzyl bromide (12) (396 mg, 1.10 mmol), CuI (21 mg,
0.11 mmol), and 2,2’-bipyridine (17 mg, 0.11 mmol) in Et2O (1 mL) cooled in an ice–water
bath, was dropwise added a 1.0 M tetrahydrofuran (THF) solution of vinylmagnesium bromide
(1.6 mL, 1.6 mmol). The cooling bath was removed, and the mixture was stirred at room
temperature for 1 h. The reaction was quenched by the addition of saturated aqueous NH4Cl and
then 28% aqueous NH3. After stirred for 30 min, the whole was extracted three times with Et2O.
The combined organic layers were washed with brine, dried over Na2SO4, and concentrated in
vacuo. The residue was purified by column chromatography (hexane/EtOAc 49:1) to give the title
compound (266 mg, 78%) as a pale-yellow oil.
5. 5-Allyl-2,3-dimethoxyphenol [76773-99-4] (14): To a stirred solution of 5-allyl-1-tert-
butyldimethylsiloxy-2,3-dimethoxybenzene (13) (74 mg, 0.24 mmol) in THF (1 mL), was added a
1.0 M THF solution of tetrabutylammonium fluoride (TBAF) (0.24 mL, 0.24 mmol). After 30 min,
0.5 M aqueous citric acid (1 mL) was added to the mixture, and the whole was extracted three
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times with EtOAc. The combined organic layers were washed with saturated aqueous NaHCO3
and brine, dried over Na2SO4, and concentrated in vacuo. The residue was purified by column
chromatography (hexane/EtOAc 9:1) to give the title compound (43 mg, 91%) as a pale-yellow
solid of mp 38–40 ◦C.
4.7.5. Synthesis of 6-Allyl-4-methoxy-1,3-benzodioxol-5-ol (20)
1. 4-Methoxy-1,3-benzodioxole [1817-95-4] (15): The title compound was prepared from
3-methoxycatechol according to the reported procedure [33] in 85% yield as colorless blocks of
mp 41–42 ◦C.
2. 4-Methoxy-1,3-benzodioxole-5-carbaldehyde [5779-99-7] (16) and 7-Methoxy-1,3-benzodioxole-4-
carbaldehyde [23731-55-7] (17): Dry DMF (0.64 mL, 8.3 mmol) and freshly distilled POCl3 (0.77 mL,
8.3 mmol) were mixed at 100 ◦C for 2 h. To the mixture, 4-methoxy-1,3-benzodioxole (15) (500 mg,
3.29 mmol) was added, and the mixture was heated at 100 ◦C. After 2 h, the reaction was quenched
by the addition of ice, and the whole was extracted three times with Et2O. The combined organic
layers were washed with water, saturated aqueous NaHCO3, and brine, dried over Na2SO4, and
concentrated in vacuo to give a crude mixture of the title compounds (3:2) as a pale brown solid.
The two isomers were separated by column chromatography (hexane/Et2O 4:1, Rf = 0.24 and 0.12,
respectively). 4-Methoxy-1,3-benzodioxole-5-carbaldehyde (16): 44% yield. Colorless needles of
mp 107–108 ◦C (EtOH). 7-Methoxy-1,3-benzodioxole-4-carbaldehyde (17): 29% yield. Colorless
needles of mp 85–86 ◦C (EtOH).
3. 4-Methoxy-1,3-benzodioxol-5-ol [23504-78-1] (18): To a solution of 4-methoxy-1,3-benzodioxole-
5-carbaldehyde (16) (100 mg, 0.555 mmol) in MeOH (1 mL), were added conc. H2SO4 (0.01 mL,
0.2 mmol) and 30% H2O2 (0.085 mL, 0.83 mmol). The mixture was stirred at room temperature
for 2.5 h, and saturated aqueous NaHCO3 was added to the mixture. The whole was extracted
three times with EtOAc, and the combined organic layers were washed with brine, dried over
Na2SO4, and concentrated in vacuo. The residual solid was purified by column chromatography
(hexane/EtOAc 9:1) to give the title compound (72 mg, 78%) as a white solid: Rf = 0.29
(hexane/EtOAc 4:1). Colorless plates of mp 58–59 ◦C (Et2O/hexane).
4. 5-Allyloxy-4-methoxy-1,3-benzodioxole [23731-59-1] (19): A mixture of 4-methoxy-1,3-
benzodioxol-5-ol (18) (67 mg, 0.40 mmol), K2CO3 (111 mg, 0.800 mmol), and allyl bromide
(0.05 mL, 0.6 mmol) in dry acetone (4 mL) was heated under reflux for 4.5 h, and water was added
to the mixture. The whole was extracted three times with EtOAc, and the combined organic layers
were washed with 15% aqueous NaOH twice and brine, dried over Na2SO4, and concentrated in
vacuo. The residue was purified by column chromatography (hexane/EtOAc 95:5) to give the title
compound (71.6 mg, 86%) as a pale-yellow oil: Rf = 0.25 (hexane/EtOAc 19:1).
5. 6-Allyl-4-methoxy-1,3-benzodioxol-5-ol [23731-60-4] (20): A solution of 5-allyloxy-4-methoxy-
1,3-benzodioxole (19) (58 mg, 0.28 mmol) in a 1:2 mixture of N-methyl-2-pyrrolidone (NMP) and
decaline (1.5 mL) was heated at 200 ◦C under microwave irradiation for 8 h. After cooled to
ambient temperature, the mixture was diluted with EtOAc, washed three times with water and
with brine, dried over Na2SO4, and concentrated in vacuo. The residue was purified by column
chromatography (hexane/EtOAc 9:1) to give the title compound (46 mg, 78%) as a pale-yellow oil:
Rf = 0.44 (hexane/EtOAc 4:1).
4.7.6. Synthesis of 5-Allyl-7-methoxy-1,3-benzodioxol-4-ol (23)
1. 7-Methoxy-1,3-benzodioxol-4-ol [23812-54-6] (21): To a solution of 7-methoxy-1,3-benzodioxole-
4-carbaldehyde (17) (100 mg, 0.555 mmol) in MeOH (1 mL), conc. H2SO4 (0.01 mL, 0.2 mmol) and
30% H2O2 (0.085 mL, 0.83 mmol) were added. The mixture was stirred at room temperature for 6 h,
and saturated aqueous NaHCO3 was added to the mixture. The whole was extracted three times
with EtOAc, and the combined organic layers were washed with brine, dried over Na2SO4, and
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concentrated in vacuo. The residual solid was purified by column chromatography (hexane/EtOAc
3:1) to give the title compound (85 mg, 92%) as a white solid: Rf = 0.13 (hexane/EtOAc 4:1).
Colorless needles of mp 104–105 ◦C (CHCl3/hexane).
2. 4-Allyloxy-7-methoxy-1,3-benzodioxole [23731-70-6] (22): A mixture of 7-methoxy-1,3-
benzodioxol-4-ol (21) (82 mg, 0.49 mmol), K2CO3 (135 mg, 0.977 mmol), and allyl bromide
(63 µL, 0.73 mmol) in dry acetone (2.5 mL) was heated under reflux for 3 h, and water was added
to the mixture. The whole was extracted three times with EtOAc, and the combined organic layers
were washed with 15% aqueous NaOH twice and brine, dried over Na2SO4, and concentrated in
vacuo. The residue was purified by column chromatography (hexane/EtOAc 95:5) to give the title
compound (83.7 mg, 82%) as a pale-yellow oil: Rf = 0.20 (hexane/EtOAc 19:1).
3. 5-Allyl-7-methoxy-1,3-benzodioxol-4-ol [76773-99-4] (23): A solution of 4-allyloxy-7-methoxy-
1,3-benzodioxole (22) (82 mg, 0.39 mmol) in a 1:4 mixture of NMP and decaline (1 mL) was heated
at 200 ◦C under microwave irradiation for 8 h. After cooled to ambient temperature, the mixture
was diluted with EtOAc, washed three times with water and with brine, dried over Na2SO4,
and concentrated in vacuo. The residue was purified by column chromatography (hexane/EtOAc
4:1) to give the title compound (68 mg, 84%) as a pale-yellow solid: Rf = 0.24 (hexane/EtOAc 4:1).
Colorless needles of mp 84–85 ◦C (EtOAc/hexane).
4.7.7. Synthesis of 5-Allyl-6,7-dimethoxy-1,3-benzodioxol-4-ol (30)
1. 6,7-Dimethoxy-1,3-benzodioxol-4-ol [22934-71-0] (24): A mixture of 6,7-dimethoxy-1,3-benzodioxole-
4-carbaldehyde (368 mg, 1.75 mmol), 30% H2O2 (0.27 mL, 2.6 mmol), and conc. H2SO4 (0.12 mL,
2.3 mmol) in MeOH (3.5 mL) was stirred at room temperature for 3 h. After addition of saturated
aqueous NaHCO3, the whole was extracted three times with EtOAc, and the combined organic
layers were washed with brine, dried over Na2SO4, and concentrated in vacuo. The residual
pale-yellow solid (1.38 g, 78%) was used as a crude title compound without further purification to
the next step.: Rf = 0.22 (hexane/EtOAc 2:1). Colorless needles of mp 111–112 ◦C (EtOAc/hexane).
2. 4-Hydroxy-6,7-dimethoxy-1,3-benzodioxol-5-carbadehyde (25): A mixture of 6,7-dimethoxy-1,3-
benzodioxol-4-ol (24) (589 mg, 2.97 mmol) and hexamethylenetetramine (834 mg, 5.94 mmol) in
refluxing trifluoroacetic acid (TFA) (3 mL) was stirred for 24 h [34]. H2O was added, and the
solution was stirred for further 30 min at 60 ◦C. After being cooled to room temperature, the whole
was extracted three times with EtOAc, and the combined organic layers were washed with brine,
dried over Na2SO4, and concentrated in vacuo. The residual solids were purified by column
chromatography (hexane/EtOAc 7:1) to give the title compound (546 mg, 81%) as a pale-yellow
solid: Rf = 0.25 (hexane/EtOAc 7:1). Colorless powder of mp 85–87 ◦C (EtOAc/hexane).
3. 4-tert-Butyldimethylsilyloxy-6,7-dimethoxy-1,3-benzodioxole-5-carbadehyde (26): To a mixture
of 4-hydroxy-6,7-dimethoxy-1,3-benzodioxole-5-carbaldehyde (25) (1.20 g, 5.31 mmol),
4-dimethylaminopyridine (DMAP) (130 mg, 1.06 mmol), and Et3N (1.5 mL, 11 mmol) in CH2Cl2
(27 mL), was added tert-butylchlorodimethylsilane (1.20 g, 7.96 mmol). The mixture was stirred at
room temperature for 3 h. After addition of saturated aqueous NaHCO3, the whole was extracted
three times with EtOAc, and the combined organic layers were washed with brine, dried over
Na2SO4, and concentrated in vacuo. The residual pale-yellow oil (2.14 g) was used as a crude
title compound without further purification to the next step.
4. 4-tert-Butyldimethylsilyloxy-6,7-dimethoxy-1,3-benzodioxole-5-methanol (27): To a solution of
the crude 4-tert-butyldimethylsiloxy-6,7-dimethoxy-1,3-benzodioxole-5-carbaldehyde (26) (2.14 g)
in EtOH (30 mL) was added NaBH4 (714 mg, 18.8 mmol). The mixture was stirred at room
temperature for 30 min. After addition of water, the whole was extracted three times with EtOAc,
and the combined organic layers were washed with brine, dried over Na2SO4, and concentrated in
vacuo. The residual solids were purified by column chromatography (hexane/EtOAc 9:1 to 5:1) to
give the title compound (1.73 g, 95% in two steps) as a colorless oil: Rf = 0.23 (hexane/EtOAc 7:1).
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5. 5-Bromomethyl-4-tert-butyldimethylsilyloxy-6,7-dimethoxy-1,3-benzodioxole (28): To a mixture of
4-tert-butyldimethylsiloxy-6,7-dimethoxy-1,3-benzodioxole-5-methanol (27) (450 mg, 1.31 mmol)
in CH2Cl2 (13 mL) was added PBr3 (0.14 mL, 1.4 mmol). The mixture was stirred at room
temperature for 30 min. After addition of water, the whole was extracted three times with CHCl3,
and the combined organic layers were washed with brine, dried over Na2SO4, and concentrated
in vacuo. The residual pale-yellow oil (552 mg) was used as a crude title compound without
further purification to the next step.
6. 5-Allyl-4-tert-butyldimethylsilyloxy-6,7-dimethoxy-1,3-benzodioxole (29): To a mixture of the
crude 5-bromomethyl-4-tert-butyldimethylsiloxy-6,7-dimethoxy-1,3-benzodioxole (28) (552 mg,
1.56 mmol), CuI (50 mg, 0.26 mmol), and 2,2’-bipyridine (41 mg, 0.26 mmol) in Et2O (4 mL)
was added a 1.0 M THF solution of vinylmagnesium bromide (2.0 mL, 2.0 mmol). The mixture
was stirred at room temperature for 30 min. After addition of water, the whole was extracted
three times with EtOAc, and the combined organic layers were washed with brine, dried over
Na2SO4, and concentrated in vacuo. The residual solids were purified by column chromatography
(hexane/EtOAc 50:1) to give the title compound (313 mg, 68% over 2 steps) as a pale-yellow oil:
Rf = 0.52 (hexane/EtOAc 7:1).
7. 5-Allyl-6,7-dimethoxy-1,3-benzodioxol-4-ol (30): To a solution of 5-allyl-4-tert-butyldimethylsiloxy-
6,7-dimethoxy-1,3-benzodioxole (29) (690 mg, 1.96 mmol) in THF (20 mL) was added a 1.0 M
THF solution of TBAF (1.96 mL, 2.0 mmol). The mixture was stirred at room temperature for
30 min. After addition of water, the whole was extracted three times with EtOAc, and the
combined organic layers were washed with brine, dried over Na2SO4, and concentrated in vacuo.
The residual solids were purified by column chromatography (hexane/EtOAc 5:1 to 4:1) to give
the title compound (462 mg, 99%) as a pale-yellow solid: Rf = 0.28 (hexane/EtOAc 4:1). Colorless
needles of mp 65–67 ◦C (EtOAc/hexane).
5. Conclusions
An enzyme catalyzing a reaction in a proposed synthetic pathway of PP-type perilla oil components,
namely, the conversion of myristicin into a monohydrate intermediate of dillapiole (compound 20) by
regiospecific hydroxylation, was cloned. The potentially harmful to humans (E)-Asarone is structurally
similar to PP-type oil components and has been identified in perilla plants grown in China [12,13].
The methoxy group of (E)-asarone may result from the hydroxylation of an intermediate. The position
of the double bond in the side chain of (E)-asarone differs from that of PP-type oil components and
thus Pf-49487 is unlikely to be involved in the biosynthesis of (E)-asarone. However, our findings
regarding Pf-49487 may help elucidate the (E)-asarone biosynthetic pathway and aid in the quality
assessment and safety evaluation of perilla products.
Little is known about the biosynthetic pathways of phenylpropanoid volatile components.
Only a few enzymes involved in the synthesis of compounds such as anethole and eugenol have
been reported, and enzymes involved in the synthesis of compounds such as apiole, myristicin, and
asarone have not been characterized. These components are important plant flavor compounds and
are also used as medicines and food supplements due to their pharmacological actions. Some of these
compounds are genotoxic or carcinogenic [8]. Further elucidation of the biosynthetic mechanisms
of phenylpropanoid volatile components may contribute to the genetic manipulation and enzymatic
production of useful compounds.
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